SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Signify Health, Inc. – ‘10-Q’ for 3/31/21 – ‘R42’

On:  Wednesday, 5/12/21, at 4:46pm ET   ·   For:  3/31/21   ·   Accession #:  1828182-21-17   ·   File #:  1-40028

Previous ‘10-Q’:  None   ·   Next:  ‘10-Q’ on 8/11/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 11/8/22 for 9/30/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/12/21  Signify Health, Inc.              10-Q        3/31/21   94:7.7M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    754K 
 2: EX-10.1     Material Contract                                   HTML     68K 
 3: EX-10.2     Material Contract                                   HTML     67K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
14: R1          Cover Page                                          HTML     78K 
15: R2          Condensed Consolidated Balance Sheets               HTML    153K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     32K 
17: R4          Condensed Consolidated Statements of Operations     HTML    111K 
18: R5          Condensed Consolidated Statements of Changes in     HTML     73K 
                Stockholders' / Members? Equity                                  
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    126K 
20: R7          Nature of Operations                                HTML     34K 
21: R8          Significant Accounting Policies                     HTML     55K 
22: R9          The COVID-19 Pandemic                               HTML     33K 
23: R10         Variable Interest Entities                          HTML     45K 
24: R11         Revenue Recognition                                 HTML     96K 
25: R12         Property and Equipment                              HTML     36K 
26: R13         Intangible Assets                                   HTML     46K 
27: R14         Accounts Payable and Accrued Expenses               HTML     34K 
28: R15         Long-Term Debt                                      HTML     44K 
29: R16         Fair Value Measurements                             HTML     82K 
30: R17         Shareholders' Equity                                HTML     38K 
31: R18         Noncontrolling Interest                             HTML     31K 
32: R19         Equity-Based Compensation                           HTML     36K 
33: R20         Loss Per Share                                      HTML     35K 
34: R21         Transaction-related Expenses                        HTML     26K 
35: R22         Commitment and Contingencies                        HTML     40K 
36: R23         Income Taxes                                        HTML     34K 
37: R24         Segment Reporting                                   HTML     56K 
38: R25         Concentrations                                      HTML     27K 
39: R26         Related Party Transactions                          HTML     30K 
40: R27         Significant Accounting Policies (Policies)          HTML     74K 
41: R28         Significant Accounting Policies (Tables)            HTML     40K 
42: R29         Variable Interest Entities (Tables)                 HTML     47K 
43: R30         Revenue Recognition (Tables)                        HTML     93K 
44: R31         Property and Equipment (Tables)                     HTML     35K 
45: R32         Intangible Assets (Tables)                          HTML     47K 
46: R33         Accounts Payable and Accrued Expenses (Tables)      HTML     34K 
47: R34         Long-Term Debt (Tables)                             HTML     46K 
48: R35         Fair Value Measurements (Tables)                    HTML     86K 
49: R36         Noncontrolling Interest (Tables)                    HTML     30K 
50: R37         Loss Per Share (Tables)                             HTML     32K 
51: R38         Commitment and Contingencies (Tables)               HTML     29K 
52: R39         Segment Reporting (Tables)                          HTML     50K 
53: R40         Nature of Operations (Details)                      HTML     54K 
54: R41         Significant Accounting Policies - Narrative         HTML     47K 
                (Details)                                                        
55: R42         Significant Accounting Policies - Cash, Cash        HTML     33K 
                Equivalents and Restricted Cash (Details)                        
56: R43         Variable Interest Entities - Narrative (Details)    HTML     38K 
57: R44         Variable Interest Entities - Schedule of Variable   HTML     86K 
                Interest Entities (Details)                                      
58: R45         Revenue Recognition - Narrative (Details)           HTML     26K 
59: R46         Revenue Recognition - Disaggregation of Revenue     HTML     40K 
                (Details)                                                        
60: R47         Revenue Recognition - Schedule of Related Balance   HTML     54K 
                Sheets Account (Details)                                         
61: R48         Revenue Recognition - Contract Assets (Details)     HTML     28K 
62: R49         Revenue Recognition - Contract Liabilities          HTML     32K 
                (Details)                                                        
63: R50         Revenue Recognition - Deferred Revenue (Details)    HTML     30K 
64: R51         Revenue Recognition - Shared Savings Payable        HTML     29K 
                (Details)                                                        
65: R52         Property and Equipment - Property and Equipment,    HTML     43K 
                net (Details)                                                    
66: R53         Property and Equipment - Narrative (Details)        HTML     28K 
67: R54         Intangible Assets - Schedule of Intangible Assets   HTML     44K 
                (Details)                                                        
68: R55         Intangible Assets - Narrative (Details)             HTML     30K 
69: R56         Intangible Assets - Schedule of Expected            HTML     39K 
                Amortization Expense (Details)                                   
70: R57         Accounts Payable and Accrued Expenses (Details)     HTML     39K 
71: R58         Long-Term Debt - Schedule of Long-Term Debt         HTML     48K 
                (Details)                                                        
72: R59         Long-Term Debt - Narrative (Details)                HTML     44K 
73: R60         Long-Term Debt - Future Principal Maturities of     HTML     37K 
                Long-Term Debt (Details)                                         
74: R61         Fair Value Measurements - Schedule of Assets and    HTML     46K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
75: R62         Fair Value Measurements - Changes in Contingent     HTML     40K 
                Consideration and Customer Equity Appreciation                   
                Rights (Details)                                                 
76: R63         Fair Value Measurements - Schedule of Valuation     HTML     55K 
                Techniques and Significant Unobservable Inputs                   
                (Details)                                                        
77: R64         Shareholders' Equity (Details)                      HTML     48K 
78: R65         Noncontrolling Interest (Details)                   HTML     39K 
79: R66         Equity-Based Compensation (Details)                 HTML     94K 
80: R67         Loss Per Share - Schedule of Earnings (Loss) Per    HTML     70K 
                Share (Details)                                                  
81: R68         Loss Per Share - Narrative (Details)                HTML     34K 
82: R69         Transaction-related Expenses - Narrative (Details)  HTML     31K 
83: R70         Commitment and Contingencies - Narrative (Details)  HTML     65K 
84: R71         Commitment and Contingencies - Summary of SEU       HTML     35K 
                Activity (Details)                                               
85: R72         Income Taxes (Details)                              HTML     49K 
86: R73         Segment Reporting - Narrative (Details)             HTML     25K 
87: R74         Segment Reporting - Schedule of Operating Segment   HTML     69K 
                Results (Details)                                                
88: R75         Concentrations (Details)                            HTML     43K 
89: R76         Related Party Transactions (Details)                HTML     38K 
90: R9999       Uncategorized Items - sgfy-20210331.htm             HTML     80K 
92: XML         IDEA XML File -- Filing Summary                      XML    165K 
13: XML         XBRL Instance -- sgfy-20210331_htm                   XML   1.68M 
91: EXCEL       IDEA Workbook of Financial Reports                  XLSX    112K 
 9: EX-101.CAL  XBRL Calculations -- sgfy-20210331_cal               XML    236K 
10: EX-101.DEF  XBRL Definitions -- sgfy-20210331_def                XML    727K 
11: EX-101.LAB  XBRL Labels -- sgfy-20210331_lab                     XML   1.59M 
12: EX-101.PRE  XBRL Presentations -- sgfy-20210331_pre              XML   1.03M 
 8: EX-101.SCH  XBRL Schema -- sgfy-20210331                         XSD    183K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              402±   573K 
94: ZIP         XBRL Zipped Folder -- 0001828182-21-000017-xbrl      Zip    318K 


‘R42’   —   Significant Accounting Policies – Cash, Cash Equivalents and Restricted Cash (Details)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.21.1
Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Accounting Policies [Abstract]        
Cash and cash equivalents $ 756.5 $ 72.6    
Restricted cash 4.4 4.4    
Total cash, cash equivalents, and restricted cash $ 760.9 $ 77.0 $ 119.4 $ 50.2

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/12/21
For Period end:3/31/214
12/31/2010-K
3/31/20
12/31/19
 List all Filings 
Top
Filing Submission 0001828182-21-000017   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 1:25:55.1pm ET